MSD has unveiled further data from a trial showing that a combination of Keytruda and chemotherapy significantly improved overall survival in patients with metastatic non-squamous non-small-cell lung cancer (NSCLC). According to results of the KEYNOTE-189 […]
GlaxoSmithKline (GSK) has signed a strategic agreement to transfer its rare disease gene therapy portfolio to Orchard Therapeutics, following a review of the rare disease unit in July 2017. GSK will take a 19.9% equity […]
Alexion Pharmaceuticals has announced that it will acquire Swedish biopharmaceutical company Wilson Therapeutics for $855m. Alexion has made a recommended public cash offer to the shareholders in Wilson Therapeutics to acquire all outstanding shares in […]
Otsuka Pharmaceutical has entered an agreement with Takara Bio for the co-development and exclusive sales rights in Japan for two of Takara’s gene therapy products. Takara will receive upfront and milestone payments from Otsuka of […]
Johnson & Johnson has lost a lawsuit that claimed baby powder manufactured by the company was responsible for a deadly cancer linked to asbestos. The company, along with talc supplier Imerys SA, must pay at […]